An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Endometrial Cancer
Trial Locations (17)

Unknown

RECRUITING

Research Site, Arkhangelsk

RECRUITING

Research Site, Barnaul

RECRUITING

Research Site, Chelyabinsk

NOT_YET_RECRUITING

Research Site, Irkutsk

RECRUITING

Research Site, Izhevsk

NOT_YET_RECRUITING

Research Site, Krasnodar

NOT_YET_RECRUITING

Research Site, Krasnoyarsk

NOT_YET_RECRUITING

Research Site, Moscow

RECRUITING

Research Site, Moscow

NOT_YET_RECRUITING

Research Site, Saint Petersburg

NOT_YET_RECRUITING

Research Site, Severodvinsk

RECRUITING

Research Site, Sochi

RECRUITING

Research Site, Tomsk

RECRUITING

Research Site, Ufa

NOT_YET_RECRUITING

Research Site, Vladivostok

NOT_YET_RECRUITING

Research Site, Yaroslavl

RECRUITING

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY